The incidence of influenza-associated hospitalizations in children in Germany

Epidemiology and Infection

Volumn 129, Issue 3, 2002, Pages 525-533

  Weigl, J A I ^a,b   Puppe, W ^a,b   Schmitt, H J ^a,b  

^a UNIVERSITY OF KIEL   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; INFLUENZA VACCINE; SIALIDASE INHIBITOR;

ADOLESCENT; AGE; AIRWAY; ASPIRATION; ASTHMA; CARDIOVASCULAR SYSTEM; CHILD; CHILD HOSPITALIZATION; CLINICAL FEATURE; COMMUNICABLE DISEASE; CONTROLLED STUDY; DOSE RESPONSE; EPIDEMIOLOGICAL DATA; FEMALE; FREQUENCY ANALYSIS; GERMANY; GESTATIONAL AGE; HEALTH CARE POLICY; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; HUMAN TISSUE; INCIDENCE; INFANT; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX; NONHUMAN; PATHOGENESIS; POPULATION RESEARCH; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; SEASONAL VARIATION; TIME; UNITED STATES; WINTER;

EID: 0036973253     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0950268802007707     Document Type: Review

References (30)

1. Michaud CM, Murray CJL, Bloom BR. Burden of disease - implications for future research. JAMA 2001; 285: 535-9.
2. Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996; 18: 64-76.
3. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating school children against influenza. N Engl J Med 2001; 344: 889-96.
4. Ministerium für Arbeit, Gesundheit und Soziales des Landes Schleswig-Holstein: Zur Gesundheitslage der Kinder in Schleswig-Holstein-Daten, Einschätzungen, Fragen. b+c computergraphik, Kiel, 1997: 3-4 and 51.
5. Gröndahl B, Puppe W, Hoppe A, Kühne I, Weigl JAI, Schmitt H-J. Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: Feasibility study. J Clin Microbiol 1999; 37: 1-7.
6. Weigl JAI, Puppe W, Gröndahl B, Schmitt H-J. Epidemiological investigation of nine respiratory pathogens in hospitalised children in Germany using multiplex reverse-transcriptase polymerase chain reaction. Eur J Clin Microbiol Infect Dis 2000; 19: 336-43.
7. Claas ECJ, Sprenger MJW, Kleter GEM, van Beck R, Quint WGV, Masurel N. Type-specific identification of influenza viruses A, B and C by polymerase chain reaction. J Virol Meth 1992; 39: 1-13.
8. Byrt T. How good is that agreement? Epidemiology 1996; 7: 561.
9. Anonymous: Ärztekammer Schleswig-Holstein: Perinatalerhebung 1997, Bad Segeberg, 1997: 13.
10. Weigl JAI, Puppe W, Schmitt H-J. The incidence of respiratory syncytial virus-associated hospitalisation in Germany. Eur J Clin Microbiol Infect Dis 2001; 20: 452-9.
11. WeigI JAI, Puppe W, Schmitt HJ. Seasonality of respiratory syncytial virus positive hospitalisations in children in Kiel, Germany, over a 7 year period. Infection 2002; 30: 186-92.
12. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalisation for respiratory disease among infants and young children. N Engl J Med 2000; 342: 232-9.
13. Nicholson KG. Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990. Epidemiol Infect 1996; 116: 51-63.
14. Fleming DM, Cross KW. Respiratory syncytial virus or influenza? Lancet 1993; 342: 1507-10.
15. Mullooly JP, Barker WH. Impact of type a influenza on children: a retrospective study. Am J Publ Health 1982; 72: 1008-16.
16. Monto AS, Sullivan KM. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect 1993; 110: 145-60.
17. Hall CB. Respiratory syncytial virus. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases, 5th ed, vol. 2. Philadelphia: Churchill Livingstone, 2000: 2084-111.
18. Liou YS, Barbour SD, Bell LM, Plotkin SA. Children hospitalised with influenza B infection. Pediatr Infect Dis J 1987; 6: 541-3.
19. Glezen WP, Decker M, Perrotta DM. Survey of underlying conditions of persons hospitalised with acute respiratory disease during influenza epidemics in Houston, 1978-1981. Am Rev Respir Dis 1987; 136: 550-5.
20. Glezen WP, Paredes A, Taber LH. Influenza in children. JAMA 1980; 243: 1345-9.
21. Gruber WC. Influenza viruses. In: Long SS, Pickering LK, Prober CG, eds. Principle and practice of paediatric infectious diseases. Edinburgh: Churchill Livingston, 1998: 1267-74.
22. Brocklebank JT, Court SDM, McQuillin J, Gardner PS. Influenza-A infection in children. Lancet 1972; 2: 477-500.
23. Anestad G. Interference between outbreaks or respiratory syncytial virus and influenza virus infection. Lancet 1982; 1: 502.
24. Brandenburg AH, Jeannet P-Y, v Steensel-Moll HA, et al. Local variability in respiratory syncytial virus disease severity. Arch Dis Child 1997; 77: 410-4.
25. Deutsche Gesellschaft zur Verhütung und Bekämpfung der Influenza e.V. Flu-Info 24. Woche. Abschlußbericht der Saison 2000-2001. Hannover 2001: 1.
26. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982; 4: 25-44.
27. Glezen WP. Influenza surveillance in an urban area. Can J Infect Dis 1993; 4: 272-4.
28. Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Griffin MR. The effect of influenza on hospitalisations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000; 342: 225-31.
29. Glezen WP. Reactive airway disorders in children: Role of respiratory viruses. Clin Chest Med 1984; 5: 635-43.
30. Hall CB, Douglas RG Jr, Geiman JM, Messner MK. Nosocomial respiratory syncytial virus infections. N Engl J Med 1975; 293: 1343-6.